The use of venetoclax (ABT-199) in the treatment of CLL
Identification of high-risk disease using Molecular profiling by Mymap
Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.
The Cassiopeia trial - assessing daratumumab in the context of stem cell transplantation
What are the advantages of multiple myeloma maintenance therapy?